Active	Status	Sponsor type	Region	Phase	Filter
14 Active 31 Inactive 45 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Litwin, Alain
INDV-6000-401, NCT04995029: Buprenorphine Extended-Release Subcutaneous Injection (RBP-6000) in High-risk Users	Completed	4	785	Canada, US	Transmucosal Buprenorphine, Extended-release Buprenorphine, RBP-6000, SUBLOCADE	Indivior Inc.	Moderate to Severe Opioid-use Disorder	06/24	06/24
NCT06384157: Proof of Concept and Dose-ranging Study of INDV-2000 in Individuals With Moderate to Severe Opioid Use Disorder	Recruiting	2	300	US	INDV-2000, Placebo	Indivior Inc.	Opioid Use Disorder	08/25	09/25
PILOT, NCT05123027: Peer Intervention to Link Overdose Survivors to Treatment	Completed	N/A	150	US	Peer Intervention to Link Overdose Survivors to Treatment (PILOT) Peer, Treatment As Usual Peer	Medical University of South Carolina, National Drug Abuse Treatment Clinical Trials Network, The Emmes Company, LLC, National Institute on Drug Abuse (NIDA)	Opioid Overdose	02/24	02/24
NCT05860959: SUBLOCADE Long-term Outcomes	Recruiting	N/A	1200	Europe, Canada, US, RoW		Indivior Inc.	Opioid Use Disorder	08/27	08/27
Hanina, Adam
NCT06276881: Visual Stimulation for Pain Relief	Completed	N/A	75	US	Visual Stimulation	Dandelion Science, National Institutes of Health (NIH), National Institute on Drug Abuse (NIDA)	Pain	12/22	05/23